Needham & Company Raises Price Target on Sapiens (SPNS) Following a Solid 4Q and Upbeat Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Sapiens (SPNS) Tops Q4 EPS by 1c; Guides FY16 Revenue Above Expectations
February 17, 2016 5:56 AM ESTSapiens (NASDAQ: SPNS) reported Q4 EPS of $0.13, $0.01 better than the analyst estimate of $0.12. Revenue for the quarter came in at $48.7 million versus the consensus estimate of $48.18 million.
GUIDANCE:
Sapiens sees FY2016 revenue of $207-211 million, versus the consensus of $205.2... More
Trading Radar for 2/17: Marriott (MAR), NVIDIA (NVDA), Priceline (PCLN), Barrick Gold (ABX), Albemarle (ALB) Report
February 16, 2016 3:29 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EST
9:15am EST
Industrial Production - Street sees 0.3%Capacity Utilization - Street sees 76.6%Earnings:
AMAG Pharma (Nasdaq: AMAG) - consensus EPS $1.16
Albany Molecular Research (Nasdaq: AMRI) - consensus EPS $0.36... More
